Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs SanDisk (SNDK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs SanDisk — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while SanDisk trades at $1,332.73 (market cap $214.24B). The key difference: SanDisk is far larger — about 6.9× GE HealthCare Technologies Inc. Common Stock's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while SanDisk pays none. Which is the better fit depends on your goals.
| GEHC | SNDK | |
|---|---|---|
Market Cap | $31.07B | $214.24B |
Volume | 3,443,020 | 8,297,270 |
Sector | Health | Technology |
52-Week High | $88.16 | $2.34K |
52-Week Low | $59.48 | $140.16 |
Enterprise Value | $39.53B | $209.65B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 10 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
SNDK trades at $1,482.33, down 0.34% amid sector-wide pressure from Chinese competition concerns. The stock shows bearish technical signals with strong analyst support (87.5% buy rating) and a $2,160 consensus price target. Recent earnings beats contrast with current negative profitability, though 2026 projections show dramatic improvement to $11.4B net income. The company maintains strong balance sheet fundamentals with $1.48B cash and manageable debt levels.
SNDK presents a compelling risk-reward opportunity with significant upside potential to analyst targets, though near-term volatility from memory sector headwinds persists. The company's AI memory positioning and projected 2026 profitability growth support long-term bullish thesis, while current technical weakness may offer attractive entry points for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About SanDisk
Sandisk is a semiconductor memory company specializing in NAND flash technology. Its storage products support consumer devices, enterprise systems, and cloud and AI infrastructure.
Read more on SNDK →
